{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T04:13:36Z","timestamp":1782792816988,"version":"3.54.5"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T00:00:00Z","timestamp":1560988800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T00:00:00Z","timestamp":1560988800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s11102-019-00971-x","type":"journal-article","created":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T07:24:24Z","timestamp":1561015464000},"page":"411-421","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Role of gamma knife radiosurgery in the treatment of prolactinomas"],"prefix":"10.1007","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9343-2480","authenticated-orcid":false,"given":"Jana","family":"Je\u017ekov\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e1clav","family":"H\u00e1na","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikul\u00e1\u0161","family":"Kos\u00e1k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Kr\u0161ek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Li\u0161\u010d\u00e1k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Vymazal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ladislav","family":"Pecen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Marek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,20]]},"reference":[{"issue":"14","key":"971_CR1","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1056\/NEJM199410063311403","volume":"331","author":"J Webster","year":"1994","unstructured":"Webster J, Piscitelli G, Polli A, Ferrari CI, Ismail I, Scanlon MF (1994) A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. Cabergoline comparative study group. N Engl J Med 331(14):904\u2013909","journal-title":"N Engl J Med"},{"issue":"3","key":"971_CR2","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1210\/jcem.82.3.3822","volume":"82","author":"A Colao","year":"1997","unstructured":"Colao A, Di Sarno A, Sarnacchiaro F, Ferona D, Di Renzo G, Merola B, Annunziato L, Lobardi G (1997) Prolactinoma resistant to standard dopamine agonists respond to chronic cabergoline treatment. J Clin Endocrinol Metab 82(3):876\u2013883","journal-title":"J Clin Endocrinol Metab"},{"key":"971_CR3","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1111\/j.1365-2265.2005.02364.x","volume":"63","author":"K Berinder","year":"2005","unstructured":"Berinder K, Stackenas I, Akre O, Hirschberg AL, Hulting AL (2005) Hyperprolactinaemia in 271 women: up to three decades of clinical follow-up. Clin Endocrinol 63:450\u2013455","journal-title":"Clin Endocrinol"},{"key":"971_CR4","doi-asserted-by":"publisher","first-page":"255","DOI":"10.2165\/00003495-199549020-00009","volume":"49","author":"CP Rains","year":"1995","unstructured":"Rains CP, Bryson HM, Cabergoline Fitton A (1995) A review of its pharmacological properties and therapeutic potential in the treatment of hyperprolactinemia and inhibition lactation. Drug 49:255\u2013279","journal-title":"Drug"},{"issue":"4","key":"971_CR5","doi-asserted-by":"publisher","first-page":"28","DOI":"10.2165\/00002018-199614040-00003","volume":"14","author":"J Webster","year":"1996","unstructured":"Webster J (1996) A comparative review of the tolerability profiles of dopamine agonists in the treatment of hyperprolactinemia and inhibition lactation. Drug Saf 14(4):28\u2013238","journal-title":"Drug Saf"},{"issue":"6","key":"971_CR6","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1111\/j.1365-2265.1994.tb02799.x","volume":"41","author":"L Vilar","year":"1994","unstructured":"Vilar L, Burke CW (1994) Quinagolide efficacy and tolerability in hyperprolactinaemic patients who are resistant to or intolerant of bromocriptine. Clin Endocrinol 41(6):821\u2013826","journal-title":"Clin Endocrinol"},{"key":"971_CR7","doi-asserted-by":"publisher","first-page":"5256","DOI":"10.1210\/jcem.86.11.8054","volume":"86","author":"A Di Sarno","year":"2001","unstructured":"Di Sarno A, Landi ML, Cappabianca P, Di Salle F, Rossi FW, Pivonello R, Di Somma C, Faggiano A, Lombardi G, Colao A (2001) Resistance to cabergoline as compared with bromocriptine in hyperprolactinemia: prevalence, clinical definition, and therapeutic strategy. J Clin Endocrinol Metab 86:5256\u20135261","journal-title":"J Clin Endocrinol Metab"},{"key":"971_CR8","doi-asserted-by":"publisher","first-page":"4721","DOI":"10.1210\/jc.2007-2758","volume":"93","author":"M Ono","year":"2008","unstructured":"Ono M, Miki N, Kawamata T, Makino R, Amano K, Seki T, Kubo O, Hori T, Takano K (2008) Prospective study of high-dose cabergoline treatment of prolactinoma in 150 patients. J Clin Endocrinol Metab 93:4721\u20134727","journal-title":"J Clin Endocrinol Metab"},{"key":"971_CR9","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1530\/EJE-12-0236","volume":"167","author":"L Vroonen","year":"2012","unstructured":"Vroonen L, Jaffrain-Rea ML, Petrossians P, Tamagno G, Cjanson P, Vilar L, Borson-Chazot F, Naves L, Brue T, Gatta B, Delemer B, Ciccareli E, Beck-Peccoz P, Caron P, Daly A, Beckers A (2012) Prolactinomas resistant to standard doses of cabergoline: a multicenter study of 92 patients. Eur J Endocrinol 167:651\u2013662","journal-title":"Eur J Endocrinol"},{"key":"971_CR10","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1530\/EJE-09-0012","volume":"160","author":"E Delgrange","year":"2009","unstructured":"Delgrange E, Daems T, Verhelst J, Abs R, Maiter D (2009) Characterization of resistence to the prolactin-lowering effects of cabergoline in macroprolactinomas: a study in 122 patients. Eur J Endocrinol 160:747\u2013752","journal-title":"Eur J Endocrinol"},{"key":"971_CR11","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1210\/jcem.87.2.8145","volume":"87","author":"B Verges","year":"2002","unstructured":"Verges B, Boureille F, Goudet P, Murat A, Beckers A, Sassolas G, Cougard P, Chambe P, Montvernay C, Calender A (2002) Pituitary disease in MEN type 1 (MEN1): data from France-Belgium MEN 1 multicenter study. J Clin Endocrinol Metab 87:457\u2013465","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"971_CR12","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1210\/er.2005-9998","volume":"27","author":"MP Gillam","year":"2006","unstructured":"Gillam MP, Molitch ME, Lombardi G, Colao A (2006) Advances in the treatment of prolactinomas. Endocr Rev 27(5):485\u2013534","journal-title":"Endocr Rev"},{"issue":"1","key":"971_CR13","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.wneu.2010.05.007","volume":"74","author":"S Tanaka","year":"2010","unstructured":"Tanaka S, Link MJ, Brown PD, Stafford SL, Young WF Jr, Pollock BE (2010) Gamma knife radiosurgery for patients with prolactin-secreting pituitary adenomas. World Neurosurg 74(1):147\u2013153","journal-title":"World Neurosurg"},{"issue":"2","key":"971_CR14","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3171\/2010.5.JNS091635","volume":"114","author":"JP Sheehan","year":"2011","unstructured":"Sheehan JP, Pouratian N, Steiner L, Laws ED, Vance ML (2011) Gamma Knife surgery for pituitary adenomas: factors related to radiological and endocrine outcomes. J Neurosurg 114(2):303\u2013309","journal-title":"J Neurosurg"},{"key":"971_CR15","doi-asserted-by":"publisher","first-page":"602","DOI":"10.3349\/ymj.2003.44.4.602","volume":"44","author":"JY Choi","year":"2003","unstructured":"Choi JY, Chang JH, Chang JW et al (2003) Radiological and hormonal responses of functioning pituitary adenomas after gamma knife radiosurgery. Yonsei Med J 44:602\u2013607","journal-title":"Yonsei Med J"},{"key":"971_CR16","doi-asserted-by":"publisher","first-page":"525","DOI":"10.3171\/jns.2002.97.3.0525","volume":"97","author":"BE Pollock","year":"2002","unstructured":"Pollock BE, Nippoldt TB, Stafford SL et al (2002) Results of stereotactic radiosurgery in patients with hormone-producing pituitary adenomas: factors associated with endocrine normalization. J Neurosurg 97:525\u2013530","journal-title":"J Neurosurg"},{"issue":"4","key":"971_CR17","doi-asserted-by":"publisher","first-page":"678","DOI":"10.3171\/jns.2005.102.4.0678","volume":"102","author":"JP Sheehan","year":"2005","unstructured":"Sheehan JP, Niranjan A, Sheehan JM et al (2005) Stereotactic radiosurgery for pituitary adenomas: an intermediate review of its safety, efficacy, and role in the neurosurgical treatment armamentarium. J Neurosurg 102(4):678\u2013691","journal-title":"J Neurosurg"},{"key":"971_CR18","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1111\/j.1365-2265.2008.03384.x","volume":"70","author":"J Je\u017ekov\u00e1","year":"2009","unstructured":"Je\u017ekov\u00e1 J, H\u00e1na V, Kr\u0161ek M et al (2009) Use of the Leksell gamma knife in the treatment of prolactinoma patients. Clin Endocrinol 70:732\u2013741","journal-title":"Clin Endocrinol"},{"key":"971_CR19","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1227\/01.NEU.0000043709.53906.31","volume":"52","author":"V Vladyka","year":"2003","unstructured":"Vladyka V, Li\u0161\u010d\u00e1k R, Novotn\u00fd J Jr et al (2003) Radiation tolerance of functioning pituitary tissue in gamma knife surgery for pituitary adenomas. Neurosurgery 52:309\u2013317","journal-title":"Neurosurgery"},{"key":"971_CR20","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1530\/EJE-10-0733","volume":"164","author":"J Marek","year":"2011","unstructured":"Marek J, Je\u017ekov\u00e1 J, H\u00e1na V et al (2011) Is it possible to avoid hypopituitarism after irradiation of pituitary adenomas by the Leksell gamma knife? Eur J Endocrinol 164:169\u2013178","journal-title":"Eur J Endocrinol"},{"key":"971_CR21","first-page":"99","volume":"1","author":"J Novotn\u00fd Jr","year":"1998","unstructured":"Novotn\u00fd J Jr, Novotn\u00fd J, Vymazal J, Li\u0161\u010d\u00e1k R, Vladyka V (1998) Assessment pf the accuracy of stereotactic target localization using magnetic resonance imaging: phantom study. J Neurosurg 1:99\u2013111","journal-title":"J Neurosurg"},{"key":"971_CR22","first-page":"169","volume-title":"Gamma knife radiosurgery","author":"J Je\u017ekov\u00e1","year":"2013","unstructured":"Je\u017ekov\u00e1 J, Marek J, Li\u0161\u010d\u00e1k R (2013) Pituitary adenomas. In: Li\u0161\u010d\u00e1k R (ed) Gamma knife radiosurgery. Nova Science, New York, pp 169\u2013188"},{"issue":"2","key":"971_CR23","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1210\/jc.2010-1692","volume":"96","author":"S Melmed","year":"2011","unstructured":"Melmed S, Casanueva FF, Hoffman AR, Kleinberg DL, Montori VM, Schlechte JA, Wass JAH (2011) Diagnosis and treatment of hyperprolactinemia: an endocrine society clinical practice guidline. J Clin Endocrinol Metab 96(2):273\u2013288","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl. 1","key":"971_CR24","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1159\/000056412","volume":"70","author":"YL Lim","year":"1998","unstructured":"Lim YL, Leem W, Kim TS et al (1998) Four years-experience in the treatment of pituitary adenomas with gamma knife radiosurgery. Stereotact Funct Neurosurg 70(Suppl. 1):95\u2013109","journal-title":"Stereotact Funct Neurosurg"},{"issue":"Suppl. 1","key":"971_CR25","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1159\/000056446","volume":"72","author":"M Hayashi","year":"1999","unstructured":"Hayashi M, Izawa M, Hiyama H et al (1999) Gamma knife radiosurgery for pituitary adenomas. Stereotact Funct Neurosurg 72(Suppl. 1):111\u2013118","journal-title":"Stereotact Funct Neurosurg"},{"issue":"Suppl. 1","key":"971_CR26","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1159\/000056445","volume":"72","author":"SH Kim","year":"1999","unstructured":"Kim SH, Huh R, Chang JW et al (1999) Gamma knife radiosurgery for functioning pituitary adenomas. Stereotact Funct Neurosurg 72(Suppl. 1):101\u2013110","journal-title":"Stereotact Funct Neurosurg"},{"issue":"Suppl. 1","key":"971_CR27","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1159\/000056444","volume":"72","author":"M Mokry","year":"1999","unstructured":"Mokry M, Ramschak-Schwarzer S, Simbrunner J et al (1999) A six year experience with the postoperative radiosurgical management of pituitary adenomas. Stereotact Funct Neurosurg 72(Suppl. 1):88\u2013100","journal-title":"Stereotact Funct Neurosurg"},{"issue":"Suppl. 3","key":"971_CR28","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3171\/jns.2000.93.supplement_3.0010","volume":"93","author":"L Pan","year":"2000","unstructured":"Pan L, Zhang N, Wang EM et al (2000) Gamma knife radiosurgery as a primary treatment for prolactinomas. J Neurosurg 93(Suppl. 3):10\u201313","journal-title":"J Neurosurg"},{"issue":"Suppl. 3","key":"971_CR29","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3171\/jns.2000.93.supplement_3.0014","volume":"93","author":"AM Landolt","year":"2000","unstructured":"Landolt AM, Lomax N (2000) Gamma knife radiosurgery for prolactinomas. J Neurosurg 93(Suppl. 3):14\u201318","journal-title":"J Neurosurg"},{"key":"971_CR30","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1227\/01.NEU.0000068702.00330.47","volume":"53","author":"Z Petrovich","year":"2003","unstructured":"Petrovich Z, Yu C, Gianotta SL, Zee CS et al (2003) Gamma knife radiosurgery for pituitary adenoma: early results. Neurosurgery 53:51\u201359 (discussion, 59-61)","journal-title":"Neurosurgery"},{"key":"971_CR31","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1227\/01.NEU.0000124750.13721.94","volume":"54","author":"JS Kuo","year":"2004","unstructured":"Kuo JS, Chen JCT, Cheng Y et al (2004) Gamma knife radiosurgery for benign cavernous sinus tumors: quantitative analysis of treatment outcomes. Neurosurgery 54:1385\u20131392","journal-title":"Neurosurgery"},{"key":"971_CR32","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1227\/01.NEU.0000223445.22938.BD","volume":"59","author":"N Pouratian","year":"2006","unstructured":"Pouratian N, Sheehan J, Jagannathan J et al (2006) Gamma knife radiosurgery for medically and surgically refractory prolactinomas. Neurosurgery 59:255\u2013264","journal-title":"Neurosurgery"},{"key":"971_CR33","doi-asserted-by":"publisher","first-page":"3400","DOI":"10.1210\/jc.2008-2772","volume":"94","author":"F Castinetti","year":"2009","unstructured":"Castinetti F, Nagai M, Morange I, Dufour H, Caron P, Chanson P, Cortet-Rudelli C, Kuhn JM, Conte-Devolx B, Regis J, Brue T (2009) Long-term results of stereotactic radiosurgery in secretory pituitary adenomas. J Clin Endocrinol Metab 94:3400\u20133407","journal-title":"J Clin Endocrinol Metab"},{"key":"971_CR34","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s11102-012-0376-x","volume":"16","author":"X Liu","year":"2013","unstructured":"Liu X, Kano H, Kondziolka D, Park KJ, Iyer A, Shin S, Niranjan A, Flickinger JC, Lunsford LD (2013) Gamma knife stereotactic radiosurgery for drug resistant or intolerant invasive prolactinomas. Pituitary 16:68\u201375","journal-title":"Pituitary"},{"key":"971_CR35","doi-asserted-by":"publisher","first-page":"6","DOI":"10.4103\/1110-208X.170551","volume":"32","author":"MF Elshirbiny","year":"2015","unstructured":"Elshirbiny MF, Hafez RFA, Ali N, Ezzeldien AS, Kassem MA (2015) Role of gamma knife radiosurgery in the management of functioning pituitary adenomas. Benha Med J 32:6\u201312","journal-title":"Benha Med J"},{"key":"971_CR36","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1007\/s11102-015-0658-1","volume":"18","author":"O Cohen-Inbar","year":"2015","unstructured":"Cohen-Inbar O, Xu Z, Schlesinger D, Vance MR, Sheehan JP (2015) Gamma Knife radiosurgery for medically and surgically refractory prolactinomas: long-term results. Pituitary 18:820\u2013830","journal-title":"Pituitary"},{"key":"971_CR37","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1111\/j.1365-2265.2006.02513.x","volume":"64","author":"J Je\u017ekov\u00e1","year":"2006","unstructured":"Je\u017ekov\u00e1 J, Marek J, H\u00e1na V et al (2006) Gamma knife radiosurgery for acromegaly\u2014long-term experience. Clin Endocrinol 64:588\u2013595","journal-title":"Clin Endocrinol"},{"issue":"3","key":"971_CR38","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1007\/s11102-014-0584-7","volume":"18","author":"J Marek","year":"2015","unstructured":"Marek J, Je\u017ekov\u00e1 J, H\u00e1na V et al (2015) Gamma knife radiosurgery for Cushing\u00b4s disease and Nelson\u00b4s syndrome. Pituitary 18(3):376\u2013384","journal-title":"Pituitary"},{"key":"971_CR39","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1111\/j.1365-2265.1992.tb01485.x","volume":"37","author":"J Webster","year":"1992","unstructured":"Webster J, Piscitelli G, Polli A, Alberton A, Falsetti L, Ferrari C, Fioretti P, Giordano G, Hermite M, Ciccarelli E, European Multicenter.: Cabergoline Dose-finding Study Group (1992) Dose depend suppression of serum prolactin by cabergoline in hyperprolactinaemia: a placebo controlled, double blind, multicentre study. European Multicenter Cabergoline Dose-findng Study Group. Clin Endocrinol 37:534\u2013541","journal-title":"Clin Endocrinol"},{"key":"971_CR40","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1530\/EJE-06-0646","volume":"156","author":"I Shimon","year":"2007","unstructured":"Shimon I, Benbassat C, Hadani M (2007) Effectivness of long-term cabergoline treatment for giant prolactinoma: study of 12 men. Eur J Endocrinol 156:225\u2013231","journal-title":"Eur J Endocrinol"},{"key":"971_CR41","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1056\/NEJMoa062222","volume":"356","author":"R Schade","year":"2007","unstructured":"Schade R, Andersohn F, Suissa S, Haverkamp W, Garbe E (2007) Dopamine agonists and the risk of cardiac-valve regurgitation. N Engl J Med 356:29\u201338","journal-title":"N Engl J Med"},{"issue":"1","key":"971_CR42","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1056\/NEJMoa054830","volume":"356","author":"R Zanettini","year":"2007","unstructured":"Zanettini R, Antonini A, Gatto G, Gentile R, Tesei S, Pezzoli G (2007) Valvular heart disease and the use of dopamine agonists for Parkinson\u00b4s disease. N Engl J Med 356(1):39\u201346","journal-title":"N Engl J Med"},{"issue":"1","key":"971_CR43","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1210\/jc.2009-1238","volume":"95","author":"OM Dekkers","year":"2010","unstructured":"Dekkers OM, Lagro J, Burman P, Jorgensen JO, Romijn JA, Pereira AM (2010) Recurrence of hyperprolactinemia after withdrawal of dopamine agonists: systematic review and meta-analysis. J Clin Endocrinol Metab 95(1):43\u201351","journal-title":"J Clin Endocrinol Metab"},{"key":"971_CR44","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1093\/qjmed\/hcs240","volume":"106","author":"P Iglesias","year":"2013","unstructured":"Iglesias P, D\u00edez JJ (2013) Macroprolactinoma: a diagnostic and therapeutic update. QJM 106:495\u2013504","journal-title":"QJM"},{"key":"971_CR45","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1093\/neurosurgery\/46.1.138","volume":"46","author":"MM O\u2019Connor","year":"2000","unstructured":"O\u2019Connor MM, Mayberg MR (2000) Effects of radiation on cerebral vasculature: a review. Neurosurgery 46:138\u2013149 (discussion 150-1)","journal-title":"Neurosurgery"},{"key":"971_CR46","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1055\/s-0035-1549223","volume":"76","author":"T Akai","year":"2015","unstructured":"Akai T, Torigoe K, Fukushima M, Iizuka H, Hayashi Y (2015) De novo aneurysm formation following gamma knife surgery for arteriovenous malformation: a case report. J Neurol Surg Rep 76:e105\u2013e108","journal-title":"J Neurol Surg Rep"},{"key":"971_CR47","doi-asserted-by":"publisher","DOI":"10.3171\/2018.5.JNS18509","author":"D Cordeiro","year":"2018","unstructured":"Cordeiro D, Xu Z, Mehta GU (2018) Hypopituitarism after gamma knife radiosurgery for pituitary adenomas: a multicenter, international study. J Neurosurg. \n                    https:\/\/doi.org\/10.3171\/2018.5.JNS18509","journal-title":"J Neurosurg"},{"key":"971_CR48","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3171\/jns.2001.95.2.0285","volume":"95","author":"H Ikeda","year":"2001","unstructured":"Ikeda H, Jokura H, Yoshimoto T et al (2001) Transsphenoidal surgery and adjuvant gamma knife treatment for growth hormone-secreting pituitary adenoma. J Neurosurg 95:285\u2013291","journal-title":"J Neurosurg"},{"issue":"Suppl 5","key":"971_CR49","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3171\/jns.2002.97.supplement_5.0415","volume":"97","author":"GC Feigl","year":"2002","unstructured":"Feigl GC, Bonelli CM, Berghold A, Mokry M (2002) Effects of gamma knife radiosurgery of pituitary adenomas on pituitary function. J Neurosurg 97(Suppl 5):415\u2013421","journal-title":"J Neurosurg"},{"key":"971_CR50","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1227\/01.NEU.0000370978.31405.A9","volume":"67","author":"JL Leenstra","year":"2010","unstructured":"Leenstra JL, Tanaka S, Kline RW, Brown PD, Lnk MJ, Nippoldt TB, Young WF Jr, Pollock BE (2010) Factors associated with endocrine deficits after stereotactic radiosurgery of pituitary adenomas. Neurosurgery 67:27\u201333","journal-title":"Neurosurgery"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-019-00971-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11102-019-00971-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-019-00971-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T23:22:12Z","timestamp":1592522532000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11102-019-00971-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,20]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["971"],"URL":"https:\/\/doi.org\/10.1007\/s11102-019-00971-x","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,20]]},"assertion":[{"value":"20 June 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}